AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2017
Mar 6, 2017
30016_dirs_2017-03-06_df1963a0-4db4-4e32-a40b-77547f713cea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2017-02-28
Reporting Person: HENDERSON REBECCA M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-28 | Common Stock | S | 700 | $144.5042 | Disposed | 20750 | Direct |
| 2017-02-28 | Common Stock | S | 5500 | $145.2305 | Disposed | 15250 | Direct |
| 2017-02-28 | Common Stock | S | 300 | $146 | Disposed | 14950 | Direct |
Footnotes
F1: Represents the weighted average sales price of the shares sold ranging from a low of $143.88 to a high of $144.87 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F2: Represents the weighted average sales price of the shares sold ranging from a low of $144.91 to a high of $145.91 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3: Represents the weighted average sales price of the shares sold ranging from a low of $145.95 to a high of $146.14 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.